News

Moderna falls on doubts over new CDC panel's backing of RSV vaccine
Moderna's shares fell 2.3% on Friday on concerns about whether a new CDC advisory panel would back the use of the company's ...
FDA expands approval of Moderna's RSV vaccine to some adults under age 60
The FDA expanded its approval of Moderna's RSV vaccine on Thursday to include adults under age 60 at increased risk of the ...
CIDRAP6d
CDC estimates show jump in NB.1.8.1 COVID variant proportions
In other developments, the ECDC today reported a slow rise in COVID activity in the Europe, which may partly reflect waning ...
FDA clears Moderna’s RSV vaccine for use in people ages 18 to 59
The Food and Drug Administration expanded the approval of Moderna’s RSV vaccine on Thursday, extending the license to include ...
Fact check: HHS misleads on mRNA vaccine safety after pulling Moderna funding
The safety of approved mRNA vaccines is well-established and, as with other vaccines, continues to be monitored by multiple ...
NewsNation on MSN6d
FDA approves expanded use of Moderna’s RSV shot
( The Hill) — The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include individuals 18-59 years of age who are at increased risk for severe illness ...
Northwest Asian Weekly1d
Dr. Helen Chu: CDC vaccine panel purge threatens public health
A leading infectious disease expert and one of the nation’s foremost COVID-19 researchers has voiced deep concerns about the ...
PharmExec6d
FDA Approves Expanded Indication for Moderna’s Respiratory Syncytial Virus Vaccine mRESVIA
RESVIA is now authorized for use in adults aged 18–59 years with an increased risk of respiratory syncytial virus-related ...